United States · FDA National Drug Code directory
Phenazopyridine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51655-007_46dd9f29-5a07-f939-e063-6394a90a6768
- Product NDC
- 51655-007
- Form
- TABLET
- Composition / generic term
- Phenazopyridine
- Labeler
- Northwind Health Company, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20220805
- Source listing expiry
- 20261231
Source-listed ingredients
- PHENAZOPYRIDINE HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 12 TABLET in 1 BOTTLE, PLASTIC (51655-007-27) · 51655-007-27
- 10 TABLET in 1 BOTTLE, PLASTIC (51655-007-53) · 51655-007-53
- 6 TABLET in 1 BOTTLE, PLASTIC (51655-007-87) · 51655-007-87
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →